Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEBITC: Dobutamine for Cerebral Blood Flow in Severe TBI
NCT02019810Phase 2Unknown
- Sponsor
- CHU Grenoble Alpes
- Start
- Oct 2014
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dobutamine in traumatic brain injury (TBI), sponsored by CHU Grenoble Alpes. Status: unknown.
02
Drugs
dobutamine
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT02019810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02019810.